Sep 9, 2026 · 24 min
Stocks retreat as oil and yields pressure market breadth
Small Caps Hit, Indexes Drop As Oil, Yields Rise: META, QLYS, KNSA In Focus
The episode explains why investors are reducing exposure in a still-rising market and identifies the technical levels that could define the next move.
- 1Rising oil prices and Treasury yields pushed major indexes and small caps lower as market breadth weakened.
- 2The Nasdaq and S&P 500 face important tests at their 50-day moving averages amid seasonal September weakness.
- 3Meta Platforms, Qualys, and Canixa Pharma show three different setups in a market demanding selective strength.
Don't miss
The hosts contrast Meta Platforms’ AI-driven rebound with the broader market’s weakening breadth and ask whether the stock can sustain its move above the 200-day moving average.
The brief
Alissa Coram and Ken Shreve assess a difficult Wednesday as major indexes, small caps, and equal-weighted measures fall under pressure from oil and Treasury yields.
Ken argues for caution rather than wholesale retreat: the major indexes remain in an uptrend, but weakening breadth, sector rotation, and September seasonality raise the stakes.
The Nasdaq and S&P 500’s 50-day moving averages emerge as key support, while deterioration in RSP and QQQE shows why broad index strength may be misleading.
Meta Platforms rebounds on news of its Muse personal AI assistant, but the hosts question whether it can hold above its 200-day moving average and build a durable consolidation.
Qualys tests its 10-week moving average on light volume, while Canixa Pharma tightens near highs with a new relative strength high and an improved Archelist revenue outlook.
The episode’s central lesson is selective exposure: technical support still matters, but weakening breadth makes relative strength and constructive stock action increasingly valuable.
What was said on this episode
12 statements · 8 positive · 3 negative · 1 mixed
Markets assign roughly 60% probability to a quarter-point Fed rate hike next week.
“Chances of an interest rate hike next week still holding right around 60%. So the market is leaning towards a quarter point rate hike by the Fed next week.”
Listen at 3:06
Investors should begin with smaller stock positions in current conditions.
“So smaller position sizes, I think, is a good idea at this stage of the game.”
Listen at 6:05
Investors should remain cautious amid weakening market signals.
“So I think investors should be cautious here.”
Listen at 8:20
Buying pullbacks may work if the market remains technically similar to late 1999.
“buying pullbacks within this chop might be the way to go here”
Listen at 8:39
Market breadth is weakening before the major indexes break down.
“breadth in the market is is weakening before the before the indexes are are weakening”
Listen at 9:37
Meta began an uptrend after moving above its 200-day moving average.
“Nice gap above the 200-day moving average for the stock today. So a nice little uptrend starting for meta platforms.”
Listen at 14:13
Investors should not chase Meta after its sharp move.
“I don't know that I'd chase the stock after a move like today”
Listen at 14:36
Qualys remains in an uptrend and may continue performing successfully.
“I think it's still on an uptrend here and still has a chance of working.”
Listen at 19:00
Archelist treats a cardiovascular inflammatory disease.
“Archelist is a drug that treats a... cardiovascular inflammatory disease”
Listen at 20:52
Archelist has become a significant money-maker for Canixa Pharma.
“it has turned into quite a moneymaker for them”
Listen at 21:05
Canixa Pharma is forming a constructive base near its 21-day average.
“This is a really nice looking base setting up at the 21-day line.”
Listen at 21:44
Canixa Pharma is one of the quality leaders in biotech.
“Conixa's, you know, one of the quality leaders here.”
Listen at 22:13
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.